Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 20, 2023, Prabhdeep Singh notified Clover Health Investments, Corp. (the "Company") that he will be stepping down from his position as Chief Growth Officer of the Company, effective March 31, 2023.

"Prabh's expertise, motivation and personal initiative has thoroughly and positively impacted our mission and transformed our team's approach to growth. We're pleased he'll be continuing to advise us, and we're very excited to see what he does next," said Andrew Toy, Chief Executive Officer of the Company.

The Company intends to enter into a Separation and Consulting Agreement with Mr. Singh (the "Separation Agreement"), pursuant to which Mr. Singh will resign from his position as Chief Growth Officer of the Company, effective March 31, 2023 (the "Separation Date"), execute a general release of claims, and provide consulting services as reasonably requested by the Company for three (3) months commencing on the Separation Date (the "Consulting Period"). Under the terms of the Separation Agreement, the Company has agreed (i) subject to the execution and non-revocation of a standard general release of claims, to pay the premiums for three months of COBRA continued medical, dental and vision coverage, if COBRA coverage is elected by Mr. Singh, and (ii) to pay Mr. Singh, during the Consulting Period, a fee of $15,000.00 per month for his services, subject to his continued service to the Company during the Consulting Period. Either Mr. Singh or the Company may terminate the consulting arrangement at any time during the Consulting Period without prior notice.

This Current Report on Form 8-K contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements regarding future events. Forward-looking statements are not guarantees of future performance and you are cautioned not to place undue reliance on such statements. Forward-looking statements in this Current Report on Form 8-K include, but are not limited to, statements regarding the contemplated execution of the Separation Agreement. These statements are subject to known and unknown risks, uncertainties and other factors that may cause actual outcomes or results to differ materially from those expressed or implied in this Current Report on Form 8-K. The forward-looking statements included in this Current Report on Form 8-K are made as of the date hereof. Except as required by law, Clover Health undertakes no obligation to update any of these forward-looking statements after the date of this Current Report on Form 8-K or to conform these statements to actual results or revised expectations.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses